|
ZNF500 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.151200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.538200E-01 |
| Normal-vs-Stage2 |
4.301200E-01 |
| Normal-vs-Stage3 |
1.954550E-01 |
| Normal-vs-Stage4 |
7.105200E-01 |
| Stage1-vs-Stage2 |
4.112800E-01 |
| Stage1-vs-Stage3 |
1.090630E-01 |
| Stage1-vs-Stage4 |
7.605200E-01 |
| Stage2-vs-Stage3 |
6.669400E-01 |
| Stage2-vs-Stage4 |
7.999400E-01 |
| Stage3-vs-Stage4 |
5.540800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.319370E-01 |
| Normal-vs-AfricanAmerican |
9.606200E-01 |
| Normal-vs-Asian |
5.764600E-01 |
| Caucasian-vs-AfricanAmerican |
1.445970E-01 |
| Caucasian-vs-Asian |
3.423200E-01 |
| AfricanAmerican-vs-Asian |
6.209200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.829800E-01 |
| Normal-vs-Female |
7.523500E-02 |
| Male-vs-Female |
1.540220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.455000E-01 |
| Normal-vs-Extreme_Weight |
9.784000E-01 |
| Normal-vs-Obese |
8.318400E-02 |
| Normal-vs-Extreme_Obese |
6.593600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.743200E-01 |
| Normal_Weight-vs-Obese |
3.496200E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.878800E-01 |
| Extreme_Weight-vs-Obese |
4.889700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.509800E-01 |
| Obese-vs-Extreme_Obese |
2.065400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.166800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.779600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.279200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.841020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.558000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.131600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.710310E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.463630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.217050E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.884430E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.104300E-02 |
| Normal-VS-Type2 PRCC |
3.496200E-01 |
| Normal-VS-KIRP CIMP |
2.569200E-01 |
| Normal-VS-Unclassified PRCC |
2.368100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.439710E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.833000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.609420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.060240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.020800E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.784200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.894000E-01 |
| Normal-vs-N1 |
1.423190E-01 |
| Normal-vs-N2 |
5.697200E-01 |
| N0-vs-N1 |
1.497760E-01 |
| N0-vs-N2 |
6.368800E-01 |
| N1-vs-N2 |
8.369400E-01 |
|
|
